CHICAGO (AP) — CHICAGO (AP) — Talis Biomedical Corp. (TLIS) on Wednesday reported a loss of $13 million in its first quarter.
On a per-share basis, the Chicago-based company said it had a loss of $7.15.
The infectious disease diagnostics company posted revenue of $73,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TLIS at https://www.zacks.com/ap/TLIS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.